Top Markets
#1 EXOD EXOD +56.80%
#2 Arowana Arowana +8.48%
#3 Fake World Assets Fake World Assets +4.62%
#4 Dual Dual +3.58%
#5 Figure Heloc Figure Heloc +3.49%
#6 Movement Movement +3.22%
#7 Ontology Gas Ontology Gas +2.75%
#8 HOME HOME +2.62%
#9 The Black Bull The Black Bull +2.59%
#10 Orochi Network Orochi Network +2.47%
Coin of the day
EXOD EXOD
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
Evgen Pharma plc Evgen Pharma plc

Evgen Pharma plc

EVG
Clasificación en acciones #38016
Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates... Evgen Pharma plc, a UK-based pharmaceutical company founded in 2014, operates at the clinical development stage, concentrating on the creation of sulforaphane-based medications. Its mission is to combat various cancers and inflammatory conditions. The firm utilizes its proprietary Sulforadex technology, which is engineered to stabilize sulforaphane, in its product development. SFX-01 stands as their principal drug candidate, currently in Phase II clinical trials for metastatic breast cancer and Phase Ib/IIa trials for glioblastoma. Furthermore, SFX-01 is being investigated in preclinical stages for haematological malignancies and analogous disorders. The company also offers out-licensing services for its innovative technology.
Precio por acción
$0.00953895
Última sincronización: 2024-05-22
Capitalización bursátil
$1.28M
Cambio (1 día)
0.06%
Cambio (1 año)
0.00%
País
GB
Comercio Evgen Pharma plc (EVG)

Categoría

Healthcare
Ratio P/B de Evgen Pharma plc (EVG)
Ratio P/B al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Evgen Pharma plc, el ratio P/B actual (TTM) es 0. Al final de 2026, el ratio P/B era 0.
Historial del ratio P/B de Evgen Pharma plc desde 2026 hasta 2026
Ratio P/B al final de cada año
Año Ratio P/B Cambiar
Not enough data for the provided dates.
Ratio P/B de empresas similares o competidoras
Empresa Ratio P/B Diferencia del ratio P/B País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.2613 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.3483 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.634 -
BE